What is the diagnosis and treatment for intermittent explosive disorder (IED)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Intermittent Explosive Disorder (IED) is characterized by repeated brief episodes of verbal or physical aggression or destruction of property, representing a failure to control aggressive impulses.

Diagnosis

  • The diagnosis of IED is based on the presence of repeated brief episodes of verbal or physical aggression or destruction of property, as described in the study 1.
  • The episodes must represent a failure to control aggressive impulses, and must not be better explained by another mental disorder or a general medical condition.

Treatment

  • While the study 1 does not provide specific treatment options for IED, treatment typically involves a combination of psychotherapy and medication, such as selective serotonin reuptake inhibitors (SSRIs) or mood stabilizers, to help manage symptoms and reduce aggressive impulses.
  • Cognitive-behavioral therapy (CBT) is also a commonly used treatment approach for IED, as it helps individuals identify and change negative thought patterns and behaviors that contribute to their aggressive outbursts.
  • It is essential to note that the study 1 provides a description of IED, but does not offer specific treatment guidelines, highlighting the need for further research and clinical guidance in this area.

From the Research

Diagnosis of Intermittent Explosive Disorder (IED)

  • IED is characterized by recurrent, problematic impulsive aggressive behavior 2
  • The disorder is associated with several cognitive and affective impairments, including emotion dysregulation, impulsive tendencies, and aggression severity 3
  • Diagnostic criteria for IED have been developed and refined over time, with recent research criteria better identifying individuals with elevated levels of aggression, impulsivity, and abnormalities in neurobiological markers of aggression 4

Treatment of Intermittent Explosive Disorder (IED)

  • Research suggests that interventions targeting serotonergic signaling may be effective in treating IED, given the role of the amygdala and orbitofrontal cortex in emotional regulation and impulse control 5
  • A personalized therapeutic approach may be necessary, given the heterogeneity of IED and the distinct cognitive-affective symptom profiles among individuals with the disorder 3
  • Further research is needed to develop more effective interventions for IED, including studies on the genetics underlying aggression and the development of consistently defined IED as a phenotype 5

Etiology and Neurobiology of Intermittent Explosive Disorder (IED)

  • IED is thought to have a multifactorial etiology, with contributions from childhood trauma, adverse family environment, and genetic factors 5
  • The amygdala and orbitofrontal cortex play a crucial role in emotional regulation and impulse control, and abnormalities in these regions may contribute to the development of IED 5
  • Research on the genetics of IED is limited, and further studies are needed to understand the underlying mechanisms and develop more effective interventions 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Intermittent explosive disorder.

Current psychiatry reports, 2000

Research

A Systematic Review of the Etiology and Neurobiology of Intermittent Explosive Disorder.

medRxiv : the preprint server for health sciences, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.